About Athersys
Athersys is a company based in United States founded in 1995.. Athersys has raised $74.43 million across 16 funding rounds from investors including HHS, Invesco Mutual Fund and Helios. Athersys operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others.
- Headquarter United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Athersys, Inc.
-
Annual Revenue
$5.33 M-3.43as on Dec 31, 2022
-
Net Profit
$-72.53 M16.58as on Dec 31, 2022
-
EBITDA
$-75.59 M11.48as on Dec 31, 2022
-
Total Equity Funding
$74.43 M (USD)
in 16 rounds
-
Latest Funding Round
$7.04 M (USD), Post-IPO
Mar 30, 2020
-
Investors
HHS
& 11 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Athersys
Athersys is a publicly listed company on the OTC with ticker symbol ATHXQ in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Athersys
Athersys has successfully raised a total of $74.43M across 16 strategic funding rounds. The most recent funding activity was a Post-IPO round of $7.04 million completed in March 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 16
- Last Round Post-IPO — $7.0M
-
First Round
First Round
(08 May 2000)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2020 | Amount | Post-IPO - Athersys | Valuation |
investors |
|
| Nov, 2019 | Amount | Post-IPO - Athersys | Valuation |
investors |
|
| Aug, 2017 | Amount | Grant - Athersys | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Athersys
Athersys has secured backing from 12 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Invesco Mutual Fund and Helios. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Greenleaf Capital Partners is engaged in investment and business consulting.
|
Founded Year | Domain | Location | |
|
Government-backed investments are directed toward healthcare, fintech, and various sectors.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Athersys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Athersys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Athersys Comparisons
Competitors of Athersys
Athersys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Lilly, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| domain | founded_year | HQ Location |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| domain | founded_year | HQ Location |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| domain | founded_year | HQ Location |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| domain | founded_year | HQ Location |
Traditional pharmaceutical medicines are developed for multiple health fields.
|
|
| domain | founded_year | HQ Location |
Developer of drugs for the treatment of multiple disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Athersys
Frequently Asked Questions about Athersys
When was Athersys founded?
Athersys was founded in 1995 and raised its 1st funding round 5 years after it was founded.
Where is Athersys located?
Athersys is headquartered in United States.
Is Athersys a funded company?
Athersys is a funded company, having raised a total of $74.43M across 16 funding rounds to date. The company's 1st funding round was a Grant of $83.41K, raised on May 08, 2000.
What is the annual revenue of Athersys?
Annual revenue of Athersys is $5.33M as on Dec 31, 2022.
What does Athersys do?
Athersys engaged in the discovery and development of therapeutic product candidates to treat different cardiovascular, neurological, inflammatory diseases. Its product portfolio includes MultiStem, a stem cell product, which is being developed as a treatment for multiple disease indications such as Ischemic stroke, Acute myocardial infarction, Inflammatory bowel disease. In addition, the Company is developing pharmaceuticals to treat indications such as obesity, certain cognitive and attention disorders, and narcolepsy or other forms of excessive daytime sleepiness.
Who are the top competitors of Athersys?
Athersys's top competitors include Merck, Roivant Sciences and AbbVie.
Is Athersys publicly traded?
Yes, Athersys is publicly traded on OTC under the ticker symbol ATHXQ.
Who are Athersys's investors?
Athersys has 12 investors. Key investors include HHS, Invesco Mutual Fund, Helios, Aspire Capital, and Greenleaf Capital Partners.
What is Athersys's ticker symbol?
The ticker symbol of Athersys is ATHXQ on OTC.